Cas:348098-29-3 2-(methylthio)pyrimidine-5-boronic acid manufacturer & supplier

Chemical Name:2-(methylthio)pyrimidine-5-boronic acid

CAS.NO:348098-29-3

Synonyms:2-(thiomethyl)pyrimidine-5-boronic acid;2-(methylthio)pyrimidin-5-ylboronic acid;2-(Methylthio)pyrimidine-5-boronic acid

Molecular Formula:C₅H₇BN₂O₂S

Molecular Weight:169.99700

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:91.54000

Exact Mass:170.03200

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(thiomethyl)pyrimidine-5-boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(Methylthio)pyrimidine-5-boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(Methylthio)pyrimidine-5-boronic acid Use and application,2-(methylthio)pyrimidin-5-ylboronic acid technical grade,usp/ep/jp grade.

Related News: Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. 2-(methylthio)pyrimidine-5-boronic acid manufacturer The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations. 2-(methylthio)pyrimidine-5-boronic acid supplier Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. 2-(methylthio)pyrimidine-5-boronic acid vendor ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. 2-(methylthio)pyrimidine-5-boronic acid factory Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions.